Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
FDA Access Data+1 Wegovy (semaglutide injection 2.4 mg) is approved to: Treat chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related condition, and in adolescents aged 1217 with obesity
Ready to experience the difference for yourself
By targeting all three pathways at once, retatrutide does more than simply reduce hunger
The option to choose between oral and injectable forms makes it more accessible and flexible for different lifestyles
Popa created "Core Med Science" to provide oral liposomal supplements with nutrients "matching" the ingredients of the most common and popular I.V
Importantly, this mechanism is tied to glucose levels, which is different from forcing insulin release regardless of what the body needs
